Acute Otitis Media: Adjuvant Therapy to Improve Outcome

Otitis Media Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00000363
• Other study ID #: NIDCD-1160
• Secondary ID: RO1 DC 02620-04
• Status: Completed
• Phase: Phase 3
• First received: November 2, 1999
• Last updated: April 21, 2006
• Est. completion date: June 2001

Study information

• Verified date: April 2006
• Source: National Institute on Deafness and Other Communication Disorders (NIDCD)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

Acute otitis media is one of the most common diseases of childhood and is one of the major causes of hearing loss in children. Despite the availability of effective antibiotic therapy for otitis media, treatment failures, persistent effusions, and recurrences are common. This Phase III outpatient study aims to test whether adjuvant therapy (an antihistamine or a corticosteroid), in addition to antibiotic therapy, improves the acute and long-term outcomes of patients with acute otitis media. This study is targeted to recruiting 200 infants (age less than one year); patient (and parent) participation is estimated to continue for one year after enrollment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: June 2001
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 2 Months to 1 Year

Eligibility

Inclusion Criteria:

• Have had two documented prior episodes of acute otitis media.

• Have no current middle ear effusion (fluid).

Exclusion Criteria:

• Have chronic otitis media.

• Have acute otitis media in addition to chronic otitis media.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Otitis
• Otitis Media

Intervention

Drug:
• Antihistamine

• Corticosteroid

Locations

Country	Name	City	State
United States	Univ of Texas Med Branch Children's Hosp	Galveston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)

Country where clinical trial is conducted

United States, 

References & Publications (2)

Chonmaitree T, Saeed K, Uchida T, Heikkinen T, Baldwin CD, Freeman DH Jr, McCormick DP. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr. 2003 Sep;143(3):377-85. — View Citation

McCormick DP, Saeed K, Uchida T, Baldwin CD, Deskin R, Lett-Brown MA, Heikkinen T, Chonmaitree T. Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. Int J Pediatr Otorhinolaryngol. 2003 Mar;67(3):221-30. — View Citation